ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity

March 2021 | 66 pages | ID: A77A15FC2841EN
GMD Research

Abstracts

ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.

Highlighted with 25 tables and 39 figures, this 66-page report “ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire ASEAN pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Industry Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Industry Opportunities
• Porter’s Fiver Forces

The trend and outlook of ASEAN industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify ASEAN pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation and Country.

Based on Formulation, the ASEAN industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations

Geographically, the following national/local markets are fully investigated:

• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Myanmar
• Cambodia
• Laos
• Brunei

For each key country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of key national industry by Formulation and Manufacturer is also included.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASEAN MARKET BY FORMULATION

3.1 Market Overview by Formulation
3.2 Tablets
3.3 Capsules
3.4 Injectable
3.5 Sprays
3.6 Other Formulations

4 ASEAN MARKET 2020-2027 BY COUNTRY

4.1 Overview of ASEAN Market
4.2 Indonesia
4.3 Thailand
4.4 Philippines
4.5 Vietnam
4.6 Singapore
4.7 Malaysia
4.8 Myanmar
4.9 Cambodia
4.10 Laos
4.11 Brunei
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of ASEAN Pharmaceutical Manufacturing Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in ASEAN Pharmaceutical Manufacturing Market
Table 4. ASEAN Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 5. ASEAN region Pharmaceutical Manufacturing Market by Country, 2017-2027, $ bn
Table 6. Indonesia Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 7. Indonesia Pharmaceutical Manufacturing Market by Company
Table 8. Thailand Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 9. Thailand Pharmaceutical Manufacturing Market by Company
Table 10. Philippines Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 11. Philippines Pharmaceutical Manufacturing Market by Company
Table 12. Vietnam Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 13. Vietnam Pharmaceutical Manufacturing Market by Company
Table 14. Singapore Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 15. Singapore Pharmaceutical Manufacturing Market by Company
Table 16. Malaysia Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 17. Philippines Pharmaceutical Manufacturing Market by Company
Table 18. Myanmar Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 19. Myanmar Pharmaceutical Manufacturing Market by Company
Table 20. Cambodia Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 21. Cambodia Pharmaceutical Manufacturing Market by Company
Table 22. Laos Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 23. Laos Pharmaceutical Manufacturing Market by Company
Table 24. Brunei Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn
Table 25. Brunei Pharmaceutical Manufacturing Market by Company

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. ASEAN Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 5. ASEAN Pharmaceutical Manufacturing Market, 2017-2027, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of ASEAN Pharmaceutical Manufacturing Market
Figure 8. Primary Restraints and Impact Factors of ASEAN Pharmaceutical Manufacturing Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of ASEAN Pharmaceutical Manufacturing Market
Figure 11. Breakdown of ASEAN Pharmaceutical Manufacturing Market by Formulation, 2020-2027, % of Revenue
Figure 12. Contribution to ASEAN 2021-2027 Cumulative Revenue by Formulation, Value ($ bn) and Share (%)
Figure 13. ASEAN Pharmaceutical Manufacturing Market: Tablets, 2017-2027, $ bn
Figure 14. ASEAN Pharmaceutical Manufacturing Market: Capsules, 2017-2027, $ bn
Figure 15. ASEAN Pharmaceutical Manufacturing Market: Injectable, 2017-2027, $ bn
Figure 16. ASEAN Pharmaceutical Manufacturing Market: Sprays, 2017-2027, $ bn
Figure 17. ASEAN Pharmaceutical Manufacturing Market: Other Formulations, 2017-2027, $ bn
Figure 18. Breakdown of ASEAN Pharmaceutical Manufacturing Market by Country, 2020 and 2027, % of Revenue
Figure 19. Contribution to ASEAN region 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 20. Pharmaceutical Manufacturing Market in Indonesia, 2017-2027, $ bn
Figure 21. Pharmaceutical Manufacturing Market in Thailand, 2017-2027, $ bn
Figure 22. Pharmaceutical Manufacturing Market in Philippines, 2017-2027, $ bn
Figure 23. Pharmaceutical Manufacturing Market in Vietnam, 2017-2027, $ bn
Figure 24. Pharmaceutical Manufacturing Market in Singapore, 2017-2027, $ bn
Figure 25. Pharmaceutical Manufacturing Market in Malaysia, 2017-2027, $ bn
Figure 26. Pharmaceutical Manufacturing Market in Myanmar, 2017-2027, $ bn
Figure 27. Pharmaceutical Manufacturing Market in Cambodia, 2017-2027, $ bn
Figure 28. Pharmaceutical Manufacturing Market in Laos, 2017-2027, $ bn
Figure 29. Pharmaceutical Manufacturing Market in Brunei, 2017-2027, $ bn